Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Former Biotech CEO Asks Supreme Court To Review Free Speech Rights
Pharmalot
Thursday, August 8, 2013 - 2:40pm
tags:
InterMune, idiopathic pulmonary fibrosis, free speech, Actimmune
Acadia Targets Pimavanserin NDA For Late 2014
Seeking Alpha
Thursday, August 8, 2013 - 2:37pm
tags:
pimavanserin, Acadia
Biotech company Intrexon shares surge 38 pct in debut
Reuters
Thursday, August 8, 2013 - 2:27pm
tags:
Intrexon, IPOs
Food Safety Concerns in China Could Fuel Zoetis’ Growth
Motley Fool
Thursday, August 8, 2013 - 2:25pm
tags:
Zoetis, China, animal health
Array BioPharma will cut 20 percent of its jobs
Yahoo/AP
Thursday, August 8, 2013 - 9:03am
tags:
Array Biopharma, layoffs, Amgen
Is There Pipeline Potential in These 3 Biotech Stocks?
Motley Fool
Thursday, August 8, 2013 - 9:02am
tags:
Regeneron, REGN-727, dupilumab, Abexinostat, Pharmacyclics, AVI-7288, Sarepta Therapeutics
Top insulin maker Novo caught up in China's widening drug probes
Yahoo/Reuters
Thursday, August 8, 2013 - 8:59am
tags:
Novo Nordisk, China
Whistle-Blower Alleges Sanofi Bribed Doctors, Herald Says
Bloomberg
Thursday, August 8, 2013 - 8:58am
tags:
whistleblowers, Sanofi, China
A.P. Pharma, Inc. Announces Planned Name Change to “Heron Therapeutics, Inc.” and Application to List on NASDAQ Capital Market
Yahoo
Thursday, August 8, 2013 - 8:39am
tags:
AP Pharma, Heron Therapeutics, NASDAQ
Generic Drugmakers Face An Increasingly Uncertain World: Moody's
Pharmalot
Thursday, August 8, 2013 - 8:33am
tags:
generics, Mylan, Novartis, Supreme Court, Teva, Actavis
Pfizer Moves Up In Market Cap Rank, Passing IBM
Forbes
Thursday, August 8, 2013 - 8:14am
tags:
Pfizer
Race to Publish Shows Glaxo Zeal to Get Leg Up in China
Bloomberg
Thursday, August 8, 2013 - 8:13am
tags:
GSK, China
Sales of Ariad's cancer drug Iclusig top estimates
Yahoo/AP
Thursday, August 8, 2013 - 8:12am
tags:
Ariad Pharmaceuticals, Iclusig, earnings
The Deal: Vivus Considers Next Steps With Big Pharma Partners
TheStreet.com
Wednesday, August 7, 2013 - 4:08pm
tags:
Vivus, Qsymia, Belviq
Pfizer to Pay $1.8 Million in Prempro Punitive Damages
Bloomberg
Wednesday, August 7, 2013 - 4:05pm
tags:
Pfizer, Prempro
Arena And Vivus - Looking At Prescriptions
Seeking Alpha
Wednesday, August 7, 2013 - 12:41pm
tags:
Vivus, Arena Pharmaceuticals, Qsymia, Belviq, obesity, prescription data
Rigel Pharma Narrows Q2 Loss
Yahoo/AP
Wednesday, August 7, 2013 - 12:40pm
tags:
earnings, Rigel Pharmaceuticals
Stada in 'exclusive talks' to buy British OTC drugmaker
Fierce Pharma
Wednesday, August 7, 2013 - 10:21am
tags:
Stada, OTC, M&A, Thornton & Ross
Lundbeck recruiting 200-plus sales reps for Brintellix launch
Fierce Pharma
Wednesday, August 7, 2013 - 10:19am
tags:
hirings, Lundbeck, antidepressants, drug launches, Brintellix
Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
Motley Fool
Wednesday, August 7, 2013 - 10:14am
tags:
Isis Pharmaceuticals, ISIS-CRPRx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.